Menu
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Applications from the field of Pharma & Biopharma focused on ICP/OES | LabRulez ICPMS
Solutions for Vaccine Testing
Brochures and specifications
| 2020 | Shimadzu
Software, MALDI, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ, ICP/MS, ICP/OES
Instrumentation
Software, MALDI, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ, ICP/MS, ICP/OES
Manufacturer
Shimadzu
Industries
Pharma & Biopharma, Clinical Research
Analysis of elemental impurities in pharmaceutical products in accordance with USP General Chapters <232> and <233>
Applications
| 2022 | Thermo Fisher Scientific
ICP/MS, ICP/OES
Instrumentation
ICP/MS, ICP/OES
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma
Analytical Workflow for Extractable and Leachable Impurities
Presentations
| 2015 | Thermo Fisher Scientific (AAPS)
GC/MSD, GC/MS/MS, GC/HRMS, GC/Orbitrap, LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap, ICP/MS, ICP/OES
Instrumentation
GC/MSD, GC/MS/MS, GC/HRMS, GC/Orbitrap, LC/HRMS, LC/MS, LC/MS/MS, LC/Orbitrap, ICP/MS, ICP/OES
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma
Support for Title 21 CFR Part 11 and Annex 11 Compliance: Agilent ICP Expert 21 CFR Part 11 software
Technical notes
| 2020 | Agilent Technologies
Software, ICP/OES
Instrumentation
Software, ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Elemental Impurities in Aspirin: USP <232>/<233> and ICH Q3D Methods Using ICP-OES
Applications
| 2021 | Agilent Technologies
ICP/OES
Instrumentation
ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis
Technical notes
| 2014 | Agilent Technologies
ICP/MS, ICP/OES
Instrumentation
ICP/MS, ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
The determination of the palladium content in valacyclovir hydrochloride using an Agilent 720 ICP-OES according to USP 35
Applications
| 2013 | Agilent Technologies
ICP/OES
Instrumentation
ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
ICP-OES ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS
Others
| 2017 | Agilent Technologies
ICP/OES
Instrumentation
ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
SPECTROSCOPY SOLUTIONS FOR PHARMACEUTICALS
Others
| 2016 | Agilent Technologies
UV–VIS spectrophotometry, ICP/MS, ICP/OES, AAS, FTIR Spectroscopy
Instrumentation
UV–VIS spectrophotometry, ICP/MS, ICP/OES, AAS, FTIR Spectroscopy
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
ALS Global capabilities (Pharmaceutical)
Brochures and specifications
| N/A | ALS Europe
GC, GC/MSD, HPLC, Ion chromatography, LC/MS, UV–VIS spectrophotometry, ICP/MS, ICP/OES, AAS, Titration, Titration Karl Fischer, FTIR Spectroscopy, Dissolution, Electrochemistry, TOC
Instrumentation
GC, GC/MSD, HPLC, Ion chromatography, LC/MS, UV–VIS spectrophotometry, ICP/MS, ICP/OES, AAS, Titration, Titration Karl Fischer, FTIR Spectroscopy, Dissolution, Electrochemistry, TOC
Manufacturer
Industries
Pharma & Biopharma
Related content
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike